RNA binding proteins: A common denominator of neuronal function and dysfunction

Neuroscience Bulletin

Volumn 30, Issue 4, 2014, Pages 610-626

  Doxakis, Epaminondas ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

alternative polyadenylation; alternative splicing; amyotrophic lateral sclerosis; anti Hu syndrome; CPEB; ELAV; FMRP; fragile X syndrome; FTLD; FUS; HU; HuB; HuC; HuD; HuR; neurodegeneration; neuron; Nova 1; Nova 2; paraneoplastic opsoclonus myoclonus ataxia; PTBP 1; PTBP 2; TDP 43

Indexed keywords

MESSENGER RNA; RNA BINDING PROTEIN;

ANIMAL; DEGENERATIVE DISEASE; GENETICS; HUMAN; METABOLISM; NERVE CELL; RNA PROCESSING;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84905966610     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-014-1443-7     Document Type: Article

References (186)

1. Doxakis E. Principles of miRNA-target regulation in metazoan models. Int J Mol Sci 2013, 14: 16280-16302.
2. Zheng S, Black DL. Alternative pre-mRNA splicing in neurons: growing up and extending its reach. Trends Genet 2013, 29: 442-448.
3. Elkon R, Ugalde AP, Agami R. Alternative cleavage and polyadenylation: extent, regulation and function. Nat Rev Genet 2013, 14: 496-506.
4. Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M, et al. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples premRNA processing and mRNA stability. Mol Cell 2011, 43: 327-339.
5. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011, 14: 459-468.
6. Jung MY, Lorenz L, Richter JD. Translational control by neuroguidin, a eukaryotic initiation factor 4E and CPEB binding protein. Mol Cell Biol 2006, 26: 4277-4287.
7. Lim CS, Alkon DL. Protein kinase C stimulates HuD-mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture. Hippocampus 2012, 22: 2303-2319.
8. Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, Bassell GJ, et al. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem 2008, 283: 18478-18482.
9. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 2004, 23: 3092-3102. (Pubitemid 39093603)
10. Ibrahim F, Nakaya T, Mourelatos Z. RNA dysregulation in diseases of motor neurons. Annu Rev Pathol 2012, 7: 323- 352.
11. Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009, 136: 701-718.
12. Jurica MS, Moore MJ. Pre-mRNA splicing: awash in a sea of proteins. Mol Cell 2003, 12: 5-14. (Pubitemid 36945033)
13. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008, 40: 1413-1415.
14. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456: 470-476. (Pubitemid 352759009)
15. Kan Z, Ro uchka EC, Gish WR, States DJ. Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res 2001, 11: 889-900. (Pubitemid 32447871)
16. de la Grange P, Gratadou L, Delord M, Dutertre M, Auboeuf D. Splicing factor and exon profiling across human tissues. Nucleic Acids Res 2010, 38: 2825-2838.
17. Castle JC, Zhang C, Shah JK, Kulkarni AV, Kalsotra A, Cooper TA, et al. Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 2008, 40: 1416-1425.
18. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, et al. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 2007, 8: R64.
19. Gray NK, Hentze MW. Regulation of protein synthesis by mRNA structure. Mol Biol Rep 1994, 19: 195-200.
20. Kozak M. Circ umstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol Cell Biol 1989, 9: 5134-5142. (Pubitemid 19275984)
21. Dyer JR, Miche l S, Lee W, Castellucci VF, Wayne NL, Sossin WS. An activity-dependent switch to cap-independent translation triggered by eIF4E dephosphorylation. Nat Neurosci 2003, 6: 219-220. (Pubitemid 36278278)
22. Pinkstaff JK, C happell SA, Mauro VP, Edelman GM, Krushel LA. Internal initiation of translation of five dendritically localized neuronal mRNAs. Proc Natl Acad Sci U S A 2001, 98: 2770-2775. (Pubitemid 32209558)
23. Polydorides AD, Okano HJ, Yang YY, Stefani G, Darnell RB. A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. Proc Natl Acad Sci U S A 2000, 97: 6350-6355. (Pubitemid 30412717)
24. Romanelli MG, Lorenzi P, Morandi C. Organization of the human gene encoding heterogeneous nuclear ribonucleoprotein type I (hnRNP I) and characterization of hnRNP I related pseudogene. Gene 2000, 255: 267-272.
25. Romanelli MG, Lore nzi P, Morandi C. Identification and analysis of the human neural polypyrimidine tract binding protein (nPTB) gene promoter region. Gene 2005, 356: 11-18. (Pubitemid 41175967)
26. Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K, et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 2007, 21: 1636-1652. (Pubitemid 47026368)
27. Licatalosi DD, Yano M, Fak JJ, Mele A, Grabinski SE, Zhang C, et al. Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev 2012, 26: 1626-1642.
28. Llorian M, Schwartz S, Clark TA, Hollander D, Tan LY, Spellman R, et al. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat Struct Mol Biol 2010, 17: 1114-1123.
29. Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon YS, et al. Genomewide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell 2009, 36: 996-1006.
30. Makeyev EV, Zhang J, C arrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 2007, 27: 435-448. (Pubitemid 47126944)
31. Bronicki LM, Jasmin BJ. Emerging complexity of the HuD/ ELAVl4 gene; implications for neuronal development, function, and dysfunction. RNA 2013, 19: 1019-1037.
32. Deschenes-Furry J, Perro ne-Bizzozero N, Jasmin BJ. The RNA-binding protein HuD: a regulator of neuronal differentiation, maintenance and plasticity. Bioessays 2006, 28: 822-833. (Pubitemid 44433744)
33. Hinman MN, Lou H. Diverse molecular functions of Hu proteins. Cell Mol Life Sci 2008, 65: 3168-3181.
34. Pascale A, Amadio M, Quatt rone A. Defining a neuron: neuronal ELAV proteins. Cell Mol Life Sci 2008, 65: 128-140. (Pubitemid 351152226)
35. Pascale A, Govoni S. The co mplex world of posttranscriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins. Cell Mol Life Sci 2012, 69: 501-517.
36. Okano HJ, Darnell RB. A hier archy of Hu RNA binding proteins in developing and adult neurons. J Neurosci 1997, 17: 3024-3037. (Pubitemid 27175816)
37. Good PJ. A conserved family o f elav-like genes in vertebrates. Proc Natl Acad Sci U S A 1995, 92: 4557-4561.
38. Akamatsu W, Fujihara H, Mitsuh ashi T, Yano M, Shibata S, Hayakawa Y, et al. The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc Natl Acad Sci U S A 2005, 102: 4625-4630. (Pubitemid 40397162)
39. Akamatsu W, Okano HJ, Osumi N, Inoue T, Nakamura S, Sakakibara S, et al. Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc Natl Acad Sci U S A 1999, 96: 9885-9890. (Pubitemid 29398827)
40. Okano H, Kawahara H, Toriya M, N akao K, Shibata S, Imai T. Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res 2005, 306: 349-356. (Pubitemid 40732760)
41. Yano M, Okano HJ, Okano H. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation. J Biol Chem 2005, 280: 12690-12699.
42. Ince-Dunn G, Okano HJ, Jensen KB, Park WY, Zhong R, Ule J, et al. Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron 2012, 75: 1067-1080.
43. Bolognani F, Merhege MA, Twiss J, P errone-Bizzozero NI. Dendritic localization of the RNA-binding protein HuD in hippocampal neurons: association with polysomes and upregulation during contextual learning. Neurosci Lett 2004, 371: 152-157. (Pubitemid 39440762)
44. Pascale A, Gusev PA, Amadio M, Dotto rini T, Govoni S, Alkon DL, et al. Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc Natl Acad Sci U S A 2004, 101: 1217-1222. (Pubitemid 38182669)
45. Quattrone A, Pascale A, Nogues X, Zha o W, Gusev P, Pacini A, et al. Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins. Proc Natl Acad Sci U S A 2001, 98: 11668-11673. (Pubitemid 32928786)
46. Tiruchinapalli DM, Caron MG, Keene JD. Activity-dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain. J Neurochem 2008, 107: 1529-1543.
47. Tiruchinapalli DM, Ehlers MD, Keene JD. Activity-dependent expression of RNA binding protein HuD and its association with mRNAs in neurons. RNA Biol 2008, 5: 157-168.
48. Bolognani F, Qiu S, Tanner DC, Paik J, Perrone-Bizzozero NI, Weeber EJ. Associative and spatial learning and memory deficits in transgenic mice overexpressing the RNA-binding protein HuD. Neurobiol Learn Mem 2007, 87: 635-643. (Pubitemid 46483121)
49. Senties-Madrid H, Vega-Boada F. Paraneopl astic syndromes associated with anti-Hu antibodies. Isr Med Assoc J 2001, 3: 94-103.
50. Lebedeva S, Jens M, Theil K, Schwanhausser B, Selbach M, Landthaler M, et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 2011, 43: 340-352.
51. Zhou HL, Hinman MN, Barron VA, Geng C, Zhou G, Luo G, et al. Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proc Natl Acad Sci U S A 2011, 108: E627-635.
52. Ratti A, Fallini C, Colombrita C, Pascale A, Laforenza U, Quattrone A, et al. Post-transcriptional regulation of neurooncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV. J Biol Chem 2008, 283: 7531-7541.
53. Buckanovich RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 1993, 11: 657-672. (Pubitemid 23321775)
54. Hormigo A, Dalmau J, Rosenblum MK, River ME, P osner JB. Immunological and pathological study of anti-Ri-associated encephalopathy. Ann Neurol 1994, 36: 896-902. (Pubitemid 24370930)
55. Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, Schold SC, Jr., et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991, 29: 241-251.
56. Pranzatelli MR. The neurobiology of the opsoclon usmyoclonus syndrome. Clin Neuropharmacol 1992, 15: 186-228.
57. Racca C, Gardiol A, Eom T, Ule J, Triller A, Darnell RB. The Neuronal splicing factor nova co-localizes with target RNAs in the dendrite. Front Neural Circuits 2010, 4: 5.
58. Yang YY, Yin GL, Darnell RB. The neuronal RNA-bin ding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A 1998, 95: 13254-13259. (Pubitemid 28509558)
59. Jensen KB, Musunuru K, Lewis HA, Burley SK, Darnel l RB. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc Natl Acad Sci U S A 2000, 97: 5740-5745. (Pubitemid 30367468)
60. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ, et al. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 2000, 25: 359-371.
61. Yano M, Hayakawa-Yano Y, Mele A, Darnell RB. Nova2 r egulates neuronal migration through an RNA switch in disabled-1 signaling. Neuron 2010, 66: 848-858.
62. Ruggiu M, Herbst R, Kim N, Jevsek M, Fak JJ, Mann MA, et al. Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc Natl Acad Sci U S A 2009, 106: 3513-3518.
63. Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi S W, et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008, 456: 464-469. (Pubitemid 352759008)
64. Eom T, Zhang C, Wang H, Lay K, Fak J, Noebels JL, et al . NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. Elife 2013, 2: e00178.
65. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314: 130-133. (Pubitemid 44547757)
66. Ayala YM, Pantano S, D'Ambrogio A, Buratti E, Brindisi A, Marchetti C, et al. Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 2005, 348: 575-588. (Pubitemid 40515670)
67. Buratti E, Baralle FE. Characterization and functional im plications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 2001, 276: 36337-36343.
68. Lattante S, Rouleau GA, Kabashi E. TARDBP and FUS mutation s associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat 2013, 34: 812-826.
69. Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, Diamo nd MI, et al. Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem 2010, 285: 26304-26314.
70. Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 2010, 9: 1104-1120.
71. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 2011, 14: 452-458.
72. Fiesel FC, Voigt A, Weber SS, Van den Haute C, Waldenmaier A, Gorner K, et al. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J 2010, 29: 209-221.
73. Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res 2009, 1305: 168-182.
74. Wang IF, Wu LS, Chang HY, Shen CK. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem 2008, 105: 797-806.
75. Feiguin F, Godena VK, Romano G, D'Ambrogio A, Klima R, Baralle FE. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett 2009, 583: 1586-1592.
76. Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P, 3rd, Herz J, et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem 2010, 285: 6826-6834.
77. Iko Y, Kodama TS, Kasai N, Oyama T, Morita EH, Muto T, et al. Domai n architectures and characterization of an RNA-binding protein, TLS. J Biol Chem 2004, 279: 44834-44840. (Pubitemid 39430895)
78. Lerga A, Hallier M, Delva L, Orvain C, Gallais I, Marie J, et al. Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 2001, 276: 6807-6816.
79. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 2010, 29: 2841-2857.
80. Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, et al. Cellfree formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 2012, 149: 753-767.
81. Kwiatkowski TJ, Jr., Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323: 1205-1208.
82. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323: 1208-1211.
83. Gerbino V, Carri MT, Cozzolino M, Achsel T. Mislocalised FUS mutants stal l spliceosomal snRNPs in the cytoplasm. Neurobiol Dis 2013, 55: 120-128.
84. Meissner M, Lopato S, Gotzmann J, Sauermann G, Barta A. Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp Cell Res 2003, 283: 184-195. (Pubitemid 36269024)
85. Schwartz JC, Ebmeier CC, Podell ER, Heimiller J, Taatjes DJ, Cech TR. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev 2012, 26: 2690-2695.
86. Braunschweig U, Gueroussov S, Plocik AM, Graveley BR, Blencowe BJ. Dynamici ntegration of splicing within gene regulatory pathways. Cell 2013, 152: 1252-1269.
87. Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long premRNAs. Nat Neurosci 2012, 15: 1488-1497.
88. Ishigaki S, Masuda A, Fujioka Y, Iguchi Y, Katsuno M, Shibata A, et al. Positi on-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep 2012, 2: 529.
89. Nakaya T, Alexiou P, Maragkakis M, Chang A, Mourelatos Z. FUS regulates genes coding for RNA-binding proteins in neurons by binding to their highly conserved introns. RNA 2013, 19: 498-509.
90. Rogelj B, Easton LE, Bogu GK, Stanton LW, Rot G, Curk T, et al. Widespread bind ing of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep 2012, 2: 603.
91. Hicks GG, Singh N, Nashabi A, Mai S, Bozek G, Klewes L, et al. Fus deficiency i n mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 2000, 24: 175-179. (Pubitemid 30094720)
92. Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, Tachibana T, et al. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 2005, 15: 587-593. (Pubitemid 40413401)
93. Mitchell JC, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, Rogelj B, et al. Overexpression of human wildtype FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol 2013, 125: 273-288.
94. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455: 903-911.
95. Hirokawa N, Niwa S, Tanaka Y. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 2010, 68: 610-638.
96. Santos MS LH, Voglmaier SM. Synaptic vesicle protein trafficking at the glutamate sy napse. Neuroscience 2009, 158: 189-203.
97. Christie SB, Akins MR, Schwob JE, Fallon JR. The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. J Neurosci 2009, 29: 1514-1524.
98. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, et al. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 1993, 3: 36-43. (Pubitemid 23063286)
99. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, et al. Absence of express ion of the FMR-1 gene in fragile X syndrome. Cell 1991, 66: 817-822. (Pubitemid 121001715)
100. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65: 905-914. (Pubitemid 121001321)
101. Antar LN, Li C, Zhang H, Carroll RC, Bassell GJ. Local functions for FMRP in axon growth cone motility and activitydependent regulation of filopodia and spine synapses. Mol Cell Neurosci 2006, 32: 37-48. (Pubitemid 43868095)
102. Ashley CT, Jr., Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family dom ains and selective RNA binding. Science 1993, 262: 563-566. (Pubitemid 23350668)
103. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, et al. FMRP stalls ribos omal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146: 247-261.
104. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 1997, 17: 1539-1547. (Pubitemid 27089800)
105. Khandjian EW, Huot ME, Tremblay S, Davidovic L, Mazroui R, Bardoni B. Biochemical evidence f or the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc Natl Acad Sci U S A 2004, 101: 13357-13362. (Pubitemid 39209670)
106. Stefani G, Fraser CE, Darnell JC, Darnell RB. Fragile X mental retardation protein is associa ted with translating polyribosomes in neuronal cells. J Neurosci 2004, 24: 7272-7276. (Pubitemid 39100696)
107. Ramos A, Hollingworth D, Pastore A. G-quartet-dependent recognition between the FMRP RGG box a nd RNA. RNA 2003, 9: 1198-1207. (Pubitemid 37151675)
108. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. The protein product of the fragile X gene, FMR1, ha s characteristics of an RNA-binding protein. Cell 1993, 74: 291-298. (Pubitemid 23221705)
109. De Boulle K, Verkerk AJ, Reyniers E, Vits L, Hendrickx J, Van Roy B, et al. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 1993, 3: 31-35. (Pubitemid 23063285)
110. Zang JB, Nosyreva ED, Spencer CM, Volk LJ, Musunuru K, Zhong R, et al. A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet 2009, 5: e1000758.
111. Darnell JC, Fraser CE, Mostovetsky O, Stefani G, Jones TA, Eddy SR, et al. Kissing complex RNAs m ediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 2005, 19: 903-918. (Pubitemid 40548059)
112. Mazroui R, Huot ME, Tremblay S, Filion C, Labelle Y, Khandjian EW. Trapping of messenger RNA by Fr agile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum Mol Genet 2002, 11: 3007-3017. (Pubitemid 35414814)
113. Muddashetty RS, Nalavadi VC, Gross C, Yao X, Xing L, Laur O, et al. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell 2011, 42: 673-688.
114. Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. A direct role for FMRP in activity-depen dent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell 2008, 14: 926-939. (Pubitemid 351757204)
115. Theis M, Si K, Kandel ER. Two previously undescribed members of the mouse CPEB family of genes and th eir inducible expression in the principal cell layers of the hippocampus. Proc Natl Acad Sci U S A 2003, 100: 9602-9607. (Pubitemid 37033974)
116. Wu L, Wells D, Tay J, Mendis D, Abbott MA, Barnitt A, et al. CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of alpha- CaMKII mRNA at synapses. Neuron 1998, 21: 1129-1139. (Pubitemid 29018082)
117. Huang YS, Kan MC, Lin CL, Richter JD. CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity a nd translational control of AMPA receptor GluR2 mRNA. EMBO J 2006, 25: 4865-4876. (Pubitemid 44607031)
118. Hake LE, Mendez R, Richter JD. Specificity of RNA binding by CPEB: requirement for RNA recognition motif s and a novel zinc finger. Mol Cell Biol 1998, 18: 685-693. (Pubitemid 28063401)
119. Richter JD. CPEB: a life in translation. Trends Biochem Sci 2007, 32: 279-285. (Pubitemid 46874928)
120. Udagawa T, Swanger S A, Takeuchi K, Kim JH, Nalavadi V, Shin J, et al. Bidirectional control of mRNA trans lation and synaptic plasticity by the cytoplasmic polyadenylation complex. Mol Cell 2012, 47: 253-266.
121. Barnard DC, Ryan K, Manley JL, Richter JD. Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation. Cell 2004, 119: 641-651. (Pubitemid 39535752)
122. Kim JH, Richter JD. RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB. Genes Dev 2007, 21: 2571-2579. (Pubitemid 47607668)
123. Atkins CM, Davare MA, Oh MC, Derkach V, Soderling TR. Bidirectional regulation of cytoplasmic polyadenylati on element-binding protein phosphorylation by Ca2+/calmodulindependent protein kinase II and protein phosphatase 1 during hippocampal long-term potentiation. J Neurosci 2005, 25: 5604-5610. (Pubitemid 40800652)
124. Atkins CM, Nozaki N, Shigeri Y, Soderling TR. Cytoplasmic polyadenylation element binding protein-dependent protein synthesis is regulated by calcium/calmodulin-dependent protein kinase II. J Neurosci 2004, 24: 5193-5201. (Pubitemid 38725402)
125. Huang YS, Jung MY, Sarkissian M, Richter JD. N-methyl-D-aspartate receptor signaling results in Aurora kinase - catalyzed CPEB phosphorylation and alpha CaMKII mRNA polyadenylation at synapses. EMBO J 2002, 21: 2139-2148. (Pubitemid 34516773)
126. Alarcon JM, Hodgman R, Theis M, Huang YS, Kandel ER, Richter JD. Selective modulation of some forms of schaffe r collateral-CA1 synaptic plasticity in mice with a disruption of the CPEB-1 gene. Learn Mem 2004, 11: 318-327. (Pubitemid 38697898)
127. Berger-Sweeney J, Zearfoss NR, Richter JD. Reduced extinction of hippocampal-dependent memories in CPEB knockou t mice. Learn Mem 2006, 13: 4-7. (Pubitemid 43200812)
128. Zearfoss NR, Alarcon JM, Trifilieff P, Kandel E, Richter JD. A molecular circuit composed of CPEB-1 and c-Jun co ntrols growth hormone-mediated synaptic plasticity in the mouse hippocampus. J Neurosci 2008, 28: 8502-8509.
129. McEvoy M, Cao G, Montero Llopis P, Kundel M, Jones K, Hofler C, et al. Cytoplasmic polyadenylation element bindin g protein 1-mediated mRNA translation in Purkinje neurons is required for cerebellar long-term depression and motor coordination. J Neurosci 2007, 27: 6400-6411. (Pubitemid 46920366)
130. Legendre M, Ritchie W, Lopez F, Gautheret D. Differential repression of alternative transcripts: a screen for miRN A targets. PLoS Comput Biol 2006, 2: e43.
131. Chi SW, Hannon GJ, Darnell RB. An alternative mode of microRNA target recognition. Nat Struct Mol Biol 2012, 19: 321-327.
132. Ji Z, Lee JY, Pan Z, Jiang B, Tian B. Progressive lengthening of 3' untranslated regions of mRNAs by alternative po lyadenylation during mouse embryonic development. Proc Natl Acad Sci U S A 2009, 106: 7028-7033.
133. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. Proliferating cells express mRNAs with shortened 3′ untranslate d regions and fewer microRNA target sites. Science 2008, 320: 1643-1647. (Pubitemid 351931255)
134. Paschou M, Paraskevopoulou MD, Vlachos IS, Koukouraki P, Hatzigeorgiou AG, Doxakis E. miRNA Regulons Associated with Synaptic Function. PLoS One 2012, 7: e46189.
135. An JJ, Gharami K, Liao GY, Woo NH, Lau AG, Vanevski F, et al. Distinct role of long 3′ UTR BDNF mRNA in spine morphol ogy and synaptic plasticity in hippocampal neurons. Cell 2008, 134: 175-187. (Pubitemid 351905742)
136. Liao GY, An JJ, Gharami K, Waterhouse EG, Vanevski F, Jones KR, et al. Dendritically targeted Bdnf mRNA is essential f or energy balance and response to leptin. Nat Med 2012, 18: 564-571.
137. Lau AG, Irier HA, Gu J, Tian D, Ku L, Liu G, et al. Distinct 3′UTRs differentially regulate activity-dependent translat ion of brain-derived neurotrophic factor (BDNF). Proc Natl Acad Sci U S A 2010, 107: 15945-15950.
138. Oe S, Yoneda Y. Cytoplasmic polyadenylation element-like sequences are involved in dendritic targeting of BDNF mRNA in h ippocampal neurons. FEBS Lett 2010, 584: 3424-3430.
139. Allen M, Bird C, Feng W, Liu G, Li W, Perrone-Bizzozero NI, et al. HuD promotes BDNF expression in brain neurons via sele ctive stabilization of the BDNF long 3′UTR mRNA. PLoS One 2013, 8: e55718.
140. Tian B, Hu J, Zhang H, Lutz CS. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Re s 2005, 33: 201-212. (Pubitemid 40276942)
141. Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D. Patterns of variant polyadenylation signal usage in human genes . Genome Res 2000, 10: 1001-1010. (Pubitemid 30608635)
142. Ji Z, Tian B. Reprogramming of 3' untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS One 2009, 4: e8419.
143. Nunes NM, Li W, Tian B, Furger A. A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence. EMBO J 2010, 29: 1523-1536.
144. Zhu H, Zhou HL, Hasman RA, Lou H. Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences. J Biol Chem 2007, 282: 2203-2210. (Pubitemid 47076748)
145. Hilgers V, Lemke SB, Levine M. ELAV mediates 3′ UTR extension in the Drosophila nervous system. Genes Dev 2012, 26: 2259-2264 .
146. Al-Ahmadi W, Al-Ghamdi M, Al-Haj L, Al-Saif M, Khabar KS. Alternative polyadenylation variants of the RNA binding protein, HuR : abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res 2009, 37: 3612-3624.
147. Dai W, Zhang G, Makeyev EV. RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res 2012, 40: 787-800.
148. Mansfield KD, Keene JD. Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyad enylation. Nucleic Acids Res 2012, 40: 2734-2746.
149. Jacobsen A, Wen J, Marks DS, Krogh A. Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res 2010, 20: 1010-1019.
150. Larsson E, Sander C, Marks D. mRNA turnover rate limits siRNA and microRNA efficacy. Mol Syst Biol 2010, 6: 433.
151. Srikantan S, Tominaga K, Gorospe M. Functional interplay between RNA-binding protein HuR and microRNAs. Curr Protein Pept Sci 2012, 13: 372-379.
152. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci U S A 2008, 105: 20297-20302.
153. Guo X, Wu Y, Hartley RS. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol 2009, 6: 575-583.
154. Young LE, Moore AE, Sokol L, Meisner-Kober N, Dixon DA. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Mol Cancer Res 2012, 10: 167-180.
155. Castelo-Branco P, Furger A, Wollerton M, Smith C, Moreira A, Proudfoot N. Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol Cell Biol 2004, 24: 4174-4183. (Pubitemid 41070991)
156. Millevoi S, Decorsiere A, Loulergue C, Iacovoni J, Bernat S, Antoniou M, et al. A physical and functional link between splicing factors promotes pre-mRNA 3′ end processing. Nucleic Acids Res 2009, 37: 4672-4683.
157. Dobson CM. Protein folding and misfolding. Nature 2003, 426: 884-890. (Pubitemid 38056880)
158. Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999, 24: 329-332. (Pubitemid 29421804)
159. Daigle JG, Lanson NA, Jr., Smith RB, Casci I, Maltare A, Monaghan J, et al. RNA-binding ability of FUS regulates neurodegeneration, cytopl asmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum Mol Genet 2013, 22: 1193-1205.
160. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral scleros is-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 2009, 284: 20329-20339.
161. Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, et al. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 2011, 9: e1000614.
162. Voigt A, Herholz D, Fiesel FC, Kaur K, Muller D, Karsten P, et al. TDP-43-mediated neuron loss in vivo requires RNA binding activity. PLoS One 2010, 5: e12247.
163. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding reg ion of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72: 245-256.
164. Hagerman PJ, Hagerman RJ. The fragile-X premutation: a maturing perspective. Am J Hum Genet 2004, 74: 805-816. (Pubitemid 38568956)
165. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21- linked ALS-FTD. Neuron 2011, 72: 257-268.
166. Shelkovnikova TA, Robinson HK, Troakes C, Ninkina N, Buchman VL. Compromised paraspeckle formation as a pathogenic factor in FUSopathies. Hum Mol Genet 2014.
167. Gilks N, Kedersha N, Ayodele M, Shen L, Stoecklin G, Dember LM, et al. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol Biol Cell 2004, 15: 5383- 5398.
168. Kiebler MA, Bassell GJ. Neuronal RNA granules: movers and makers. Neuron 2006, 51: 685-690. (Pubitemid 44374907)
169. Wang DO, Martin KC, Zukin RS. Spatially restricting gene expression by local translation at synapses. Trends Neurosci 2010, 33: 173-182.
170. Bosco DA,Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ, Jr., et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate in to stress granules. Hum Mol Genet 2010, 19: 4160-4175.
171. Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult . J Neurochem 2009, 111: 1051- 1061.
172. Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with inc reased risk for ALS. Nature 2010, 466: 1069-1075.
173. Hart MP, Gitler AD. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J Neurosci 2012, 32: 9133-9142.
174. Hua Y, Zhou J. Survival motor neuron protein facilitates assembly of stress granules. FEBS Lett 2004, 572: 69-74. (Pubitemid 39092515)
175. Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderweyde T, Citro A, Mehta T, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: an alysis of cultured cells and pathological brain tissue. PLoS One 2010, 5: e13250.
176. King A, Sweeney F, Bodi I, Troakes C, Maekawa S, Al-Sarraj S. Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathology 2010, 30: 408-419.
177. McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010, 69: 918-929.
178. Vanderweyde T, Yu H, Varnum M, Liu-Yesucevitz L, Citro A, Ikezu T, et al. Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies. J Neurosci 2012, 32: 8270-8283.
179. Buchan JR, Kolaitis RM, Taylor JP, Parker R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 2013, 153: 1461-1474.
180. Cuervo AM, Dice JF. Age-related decline in chaperonemediated autophagy. J Biol Chem 2000, 275: 31505-31513.
181. Wolozin B. Regulated protein aggregation : stress granules and neurodegeneration. Mol Neurodegener 2012, 7: 56.
182. Cougot N, Bhattacharyya SN, Tapia-Arancibia L, Bordonne R, Filipowicz W, Bertrand E, et al. Dendrites of mammalian neurons contain specialized P-body-like s tructures that respond to neuronal activation. J Neurosci 2008, 28: 13793-13804.
183. Vessey JP, Vaccani A, Xie Y, Dahm R, Karra D, Kiebler MA, et al. Dendritic localization of the translational repressor Pumilio 2 and its contribution to dend ritic stress granules. J Neurosci 2006, 26: 6496-6508. (Pubitemid 44318330)
184. Mallucci GR. Prion neurodegeneration: starts and stops at the synapse. Prion 2009, 3: 195-201.
185. Selkoe DJ. Alzheimer's disease is a synaptic failure. Sci ence 2002, 298: 789-791. (Pubitemid 35231524)
186. Shahidullah M, Le Marchand SJ, Fei H, Zhang J, Pandey UB, Dalva MB, et al. Defects in synapse structure and function precede motor neuron degeneration in drosop hila models of FUS-Related ALS. J Neurosci 2013, 33: 19590-19598.